BnH-015B

N/A

Report date: 2024/08/08 20:00:07

NME

Base Information

Drug NameBnH-015B

Drug Alias NameBnH-015B

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 modulators

TargetsGlutamate [NMDA] receptor subunit epsilon 2

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBnH Research Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

ATC CodeN/A